HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Williamson Selected Research

Wounds and Injuries (Trauma)

10/2008Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1beta and MIP-2 in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Williamson Research Topics

Disease

7beta-Thalassemia (Cooley's Anemia)
09/2006 - 12/2002
3Hemoglobinopathies
01/2004 - 12/2002
2Alzheimer Disease (Alzheimer's Disease)
01/2019 - 01/2017
2Neurodegenerative Diseases (Neurodegenerative Disease)
02/2018 - 01/2003
2Neoplasms (Cancer)
07/2017 - 09/2004
2Hepatolenticular Degeneration (Wilson's Disease)
11/2004 - 01/2004
2Liver Diseases (Liver Disease)
11/2004 - 01/2004
2Tobacco Use Disorder (Nicotine Dependence)
02/2004 - 01/2004
2Sickle Cell Anemia (Hemoglobin S Disease)
01/2004 - 12/2002
2Thalassemia
02/2003 - 01/2003
1Cognitive Dysfunction
01/2019
1Parkinson Disease (Parkinson's Disease)
02/2018
1Retinal Neovascularization
01/2018
1Pathologic Neovascularization
01/2018
1Choroidal Neovascularization
01/2018
1Toxic Optic Neuropathy
01/2018
1Melanoma (Melanoma, Malignant)
07/2017
1Dementia (Dementias)
01/2017
1Inflammation (Inflammations)
10/2008
1Brain Injuries (Brain Injury)
10/2008
1Wounds and Injuries (Trauma)
10/2008
1Anemia
09/2006
1alpha-Thalassemia
11/2005
1Friedreich Ataxia (Friedreich's Ataxia)
01/2003
1Acute Erythroblastic Leukemia (Erythroleukemia)
12/2002
1Multiple Sclerosis
05/2002

Drug/Important Bio-Agent (IBA)

7beta-Globins (beta Globin)IBA
03/2006 - 12/2002
2Pharmaceutical PreparationsIBA
07/2017 - 10/2008
2Codon (Codons)IBA
04/2005 - 01/2003
2Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
02/2004 - 01/2004
2Fetal Hemoglobin (Hemoglobin F)IBA
01/2004 - 12/2002
1Retinaldehyde (Retinal)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1astaxanthine (astaxanthin)IBA
02/2018
1Biological ProductsIBA
02/2018
1Neuroprotective AgentsIBA
02/2018
1AminoquinolinesIBA
01/2018
1ApelinIBA
01/2018
1Antimalarials (Antimalarial Agents)IBA
01/2018
1Phosphotransferases (Kinase)IBA
07/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2017
1ApolipoproteinsIBA
01/2017
1Apolipoproteins E (ApoE)IBA
01/2017
1ErythropoietinFDA Link
10/2008
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2008
1Hemoglobins (Hemoglobin)IBA
09/2006
1RNA Splice SitesIBA
09/2006
1alpha-GlobinsIBA
11/2005
1CopperIBA
11/2004
1HTI 042IBA
09/2004
1NicotineFDA Link
02/2004
1FrataxinIBA
01/2003
1gamma-GlobinsIBA
12/2002
1HLA Antigens (Human Leukocyte Antigens)IBA
05/2002

Therapy/Procedure

6Therapeutics
02/2018 - 01/2003
1Lasers (Laser)
01/2018
1Cell Transplantation
11/2004
1Transplantation
01/2004
1Stem Cell Transplantation
01/2004